Proposed framework for biological aging in precision longevity medicine
This abstract proposes an exploratory framework using repeated biological-age measurements to judge personalized longevity strategies; it reports no results and notes that clinical implementation remains limited. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract states that biological aging is not fixed and can be reversible. [1]
The authors propose an exploratory framework using longitudinal biological-age assessment to evaluate personalized longevity strategies. [1]
Race, sex and chronological age modulate the predictive performance of current biological aging measures. [1]
The source at a glance
- Study type / format
- Review abstract proposing an exploratory framework
- Population / context
- People of the same chronological age with differing health, discussed in a review abstract
- Summary based on
- Study abstract
- Original publication
- August 22, 2026
Biological age as a modifiable measure
The abstract describes aging as a complex biological phenomenon and notes that health can differ greatly among people of the same chronological age. It presents biological age as an integrative measure of physiological and molecular deterioration that may be more useful for promoting longevity. According to the abstract, biological aging is not a fixed process and can be reversible. Many markers exist: epigenetic clocks use aging-related DNA methylation patterns to predict morbidity and mortality, and other omics methods or clinical biomarker-derived phenotypic aging can assess aging in real time.
Supporting source [1]
Proposed longitudinal framework and reported barriers
The authors propose an exploratory framework that uses longitudinal assessment of biological aging to evaluate whether personalized longevity strategies succeed. They mention precision nutrition strategies, tailored physical activity regimes and pharmaceutics as ways to intervene on unhealthy aging trajectories, but state that integration of such strategies into standard clinical care has been limited. They also report that race, sex and chronological age modulate the predictive performance of current biological aging measures, and that implementing these measures in clinical practice has been challenging.
Supporting source [1]
Abstract-only scope and future outlook
The abstract points to advances over the past decade, including validation of complementary aging measures, increasing digitalization of healthcare data and rapid growth of aging-focused research, as bringing the field closer to this goal. It states that important barriers persist but suggests a future in which precision longevity medicine meaningfully advances healthspan and lifespan. This is a proposal, not a validated clinical tool; the abstract reports no study design, sample, follow-up or outcome data, and the full text was not reviewed.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. No study design, sample, follow-up or outcome data are reported. The framework is proposed, not validated, and the abstract describes no clinical or lifespan results.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Tuminello S, Anika R, Turner W, Joyama Y, Lazaro L, Taioli E. · europepmc.org · August 22, 2026